Atherosclerosis
Applied
Type
ReinforcementConfidence
95%
Created
Mar 19, 2026
Evidence
1 source
Rationale
The 2025 AHA Heart Disease and Stroke Statistics report provides the most current epidemiological context for atherosclerotic disease. Integrating this citation reinforces the foundational statements regarding the prevalence and systemic implications of upper extremity atherosclerosis. Additionally, abbreviations (BP, LIMA) were expanded on first use to comply with the updated formatting requirements.
Evidence
Martin SS et al. 2025 Heart Disease and Stroke Statistics: A Report of US and Global Data From the American Heart Association. Circulation. 2025. PMID: 39866113.
Verified sourceThe Statistical Update represents a critical resource for the lay public, policymakers, media professionals, clinicians, health care administrators, researchers, health advocates, and others seeking the best available data on these factors and conditions.
Content Changes
removedadded
<!-- type: background --> Atherosclerotic disease is the **most common etiology of chronic upper extremity arterial occlusive disease** in older adults and typically involves the **proximal great vessels**, particularly the **ostial/proximal subclavian artery** (and less commonly the innominate), followed by axillary/brachial disease. [@shadman2004] [@martin2025] **Clinical clues suggesting hemodynamically significant subclavian/innominate disease** - **Inter-arm systolic blood pressure (BP) difference >=15-20 mmHg**, diminished pulses, supraclavicular bruit. [@shadman2004] - Vertebrobasilar symptoms with arm exertion suggests **subclavian steal** (see [[Cerebrovascular Disease|Ch. 7]]). [@shadman2004] - Angina/ischemia in patients with a **LIMA****left internal mammary artery (LIMA)** coronary graft suggests **coronary-subclavian steal** and warrants prompt evaluation. [@angle2010] **Indications for revascularization (typical)** Revascularization is generally recommended for **symptomatic** lesions (rather than asymptomatic stenosis) and should be individualized based on anatomic severity, symptom mechanism, and procedural risk. [@esc2017] Common indications include: 1. **Lifestyle-limiting arm claudication** attributable to subclavian/innominate stenosis/occlusion. [@esc2017] 2. **Critical hand ischemia** (rest pain, ulcers, tissue loss) when due to correctable proximal inflow disease. [@esc2017] 3. **Embolization** from a proximal lesion (ulcerated plaque or aneurysmal disease) with recurrent distal ischemic events. [@esc2017] 4. **Subclavian steal syndrome** with reproducible vertebrobasilar symptoms and confirmed hemodynamic steal physiology. [@shadman2004] 5. **Coronary-subclavian steal** in patients with LIMA grafts (symptomatic or high-risk anatomy). [@angle2010] 6. **Pre-emptive left subclavian artery (LSA) revascularization** may be indicated in selected patients undergoing [[Thoracic and Complex Aortic Disease|thoracic endovascular aortic repair (TEVAR)]] when coverage risks posterior circulation or spinal cord ischemia. [@matsumura2009] **Treatment strategy (overview)** - **Best medical therapy** (antiplatelet therapy, statin therapy, smoking cessation, BP/diabetes control) is mandatory in all patients because upper extremity atherosclerosis is a marker of systemic cardiovascular risk. [@hiatt2015] [@esc2017] [@martin2025] - **Endovascular-first** (angioplasty +/- stenting) is commonly favored for focal proximal stenoses due to high technical success and low morbidity; open reconstruction is reserved for long occlusions, failed endovascular therapy, complex anatomy, or specific operative contexts. [@angle2010] [@rutherford2018-rutherford]